Nectar Lifesciences Limited NECLIFE.NS Stock
Nectar Lifesciences Limited Price Chart
Nectar Lifesciences Limited NECLIFE.NS Financial and Trading Overview
| Nectar Lifesciences Limited stock price | 32.8 INR |
| Previous Close | 21.4 INR |
| Open | 21.35 INR |
| Bid | 20.1 INR x 0 |
| Ask | 20.1 INR x 0 |
| Day's Range | 19.95 - 21.35 INR |
| 52 Week Range | 14.5 - 30.9 INR |
| Volume | 969.06K INR |
| Avg. Volume | 322.12K INR |
| Market Cap | 4.5B INR |
| Beta (5Y Monthly) | 0.583561 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.36 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 21, 2020 |
| 1y Target Est | 42 INR |
NECLIFE.NS Valuation Measures
| Enterprise Value | 11.48B INR |
| Trailing P/E | N/A |
| Forward P/E | 6.7508416 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.29492366 |
| Price/Book (mrq) | 0.43279296 |
| Enterprise Value/Revenue | 0.753 |
| Enterprise Value/EBITDA | 21.288 |
Trading Information
Nectar Lifesciences Limited Stock Price History
| Beta (5Y Monthly) | 0.583561 |
| 52-Week Change | -4.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 30.9 INR |
| 52 Week Low | 14.5 INR |
| 50-Day Moving Average | 17.44 INR |
| 200-Day Moving Average | 19.97 INR |
NECLIFE.NS Share Statistics
| Avg. Volume (3 month) | 322.12K INR |
| Avg. Daily Volume (10-Days) | 982.98K INR |
| Shares Outstanding | 224.26M |
| Float | 101.16M |
| Short Ratio | N/A |
| % Held by Insiders | 57.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -1.58% |
| Operating Margin (ttm) | -0.33% |
| Gross Margin | 23.96% |
| EBITDA Margin | 3.53% |
Management Effectiveness
| Return on Assets (ttm) | -0.14% |
| Return on Equity (ttm) | -2.24% |
Income Statement
| Revenue (ttm) | 15.25B INR |
| Revenue Per Share (ttm) | 68.09 INR |
| Quarterly Revenue Growth (yoy) | -18.39% |
| Gross Profit (ttm) | 3.65B INR |
| EBITDA | 539.47M INR |
| Net Income Avi to Common (ttm) | -241828992 INR |
| Diluted EPS (ttm) | -1.08 |
| Quarterly Earnings Growth (yoy) | -68.50% |
Balance Sheet
| Total Cash (mrq) | 178.94M INR |
| Total Cash Per Share (mrq) | 0.78 INR |
| Total Debt (mrq) | 7.54B INR |
| Total Debt/Equity (mrq) | 70.81 INR |
| Current Ratio (mrq) | 1.382 |
| Book Value Per Share (mrq) | 46.327 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.34B INR |
| Levered Free Cash Flow (ttm) | 280.26M INR |
Profile of Nectar Lifesciences Limited
| Country | India |
| State | N/A |
| City | Chandigarh |
| Address | SCO 38-39 |
| ZIP | 160009 |
| Phone | 91 17 2304 7777 |
| Website | https://www.neclife.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides phytochemicals and empty hard gelatin capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Q&A For Nectar Lifesciences Limited Stock
What is a current NECLIFE.NS stock price?
Nectar Lifesciences Limited NECLIFE.NS stock price today per share is 32.8 INR.
How to purchase Nectar Lifesciences Limited stock?
You can buy NECLIFE.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nectar Lifesciences Limited?
The stock symbol or ticker of Nectar Lifesciences Limited is NECLIFE.NS.
Which industry does the Nectar Lifesciences Limited company belong to?
The Nectar Lifesciences Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nectar Lifesciences Limited have in circulation?
The max supply of Nectar Lifesciences Limited shares is 224.26M.
What is Nectar Lifesciences Limited Price to Earnings Ratio (PE Ratio)?
Nectar Lifesciences Limited PE Ratio is 91.11111000 now.
What was Nectar Lifesciences Limited earnings per share over the trailing 12 months (TTM)?
Nectar Lifesciences Limited EPS is 0.36 INR over the trailing 12 months.
Which sector does the Nectar Lifesciences Limited company belong to?
The Nectar Lifesciences Limited sector is Healthcare.